Diagnosis of latent tuberculosis in patients with systemic lupus erythematosus: T.SPOT.TB versus tuberculin skin test

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Arenas Miras, Maria Del Mar ^a   Hidalgo Tenorio, Carmen ^a   Jimenez Gamiz, Pilar ^a   Jiménez Alonso, Juan ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC EQUIPMENT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; T.SPOT.TB TEST; TUBERCULIN TEST; UNIVERSITY HOSPITAL; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DEVICES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LATENT TUBERCULOSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUBERCULIN TEST;

EID: 84902184357     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/291031     Document Type: Article

References (28)

1. George C., Tsokos M. D., Systemic lupus erythematosus. The New England Journal of Medicine 2011 365 2110 2121 10.1056/NEJMra1100359
2. Cervera R., Khamashta M. A., Font J., Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003 82 5 299 308 2-s2.0-0141891339 10.1097/01.md.0000091181.93122.55 (Pubitemid 37229465)
3. Greenberg S. B., Infections in the immunocompromised rheumatologic patients. Critical Care Clinics 2002 18 4 931 956 2-s2.0-0036839043 10.1016/S0749-0704(02)00022-2 (Pubitemid 35215569)
4. Victorio-Navarra S. T., Dy E. E., Arroyo C. G., Torralba T. P., Tuberculosis among filipino patients with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 1996 26 3 628 634 10.1016/S0049-0172(96)80013-8 (Pubitemid 27024199)
5. Yun J. E., Lee S. W., Kim T. H., The incidence and characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clinical and Experimental Rheumatology 2002 20 2 127 132 2-s2.0-0035990146
6. Sayarlioglu M., Inanc M., Kamali S., Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extra-pulmonary localization. Lupus 2004 13 4 274 278 2-s2.0-2442517195 10.1191/ 0961203303lu529xx (Pubitemid 38649628)
7. Tam L.-S., Li E. K., Wong S.-M., Szeto C.-C., Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scandinavian Journal of Rheumatology 2002 31 5 296 300 2-s2.0-0036032366 10.1080/030097402760375205 (Pubitemid 35252543)
8. Zhang L., Wang D. X., Ma L., A clinical study of tuberculosis infection in systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 2008 47 10 808 810 2-s2.0-65849206768
9. Hou C. L., Tsai Y. C., Chen L. C., Huang J. L., Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared. Clinical Rheumatology 2008 27 5 557 563 2-s2.0-41849101059 10.1007/s10067-007-0741-8 (Pubitemid 351494010)
10. Erdozain J. G., Ruiz-Irastorza G., Egurbide M. V., Martinez-Berriotxoa A., Aguirre C., High risk of tuberculosis in systemic lupus erythematosus? Lupus 2006 15 4 232 235 2-s2.0-33646227449 10.1191/0961203306lu2289xx
11. Vadillo Font C., Hernández-García C., Pato E., Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases. Revista Clínica Española 2003 203 4 178 182 10.1016/S0014-2565(03)71232-6 (Pubitemid 36656552)
12. León R. G., Rasco R. G., Palomares E. C., Hernández F. J. G., Palma M. J. C., Román J. S., Tuberculosis in a cohort of patients with systemic lupus erythematosus. Reumatología Clínica 2010 6 5 256 261 10.1016/j.reuma.2009.11.002
13. Jick S. S., Lieberman E. S., Rahman M. U., Choi H. K., Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Care and Research 2006 55 1 19 26 2-s2.0-32544459126 10.1002/art.21705 (Pubitemid 43235123)
14. González-Martín J., García-García J. M., Anibarro L., Consensus document on the diagnosis, treatment and prevention of tuberculosis. Archivos de Bronconeumología 2010 46 5 255 274 10.1016/S1579-2129(10)70061-6
15. Diel R., Goletti D., Ferrara G., Interferon- γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. European Respiratory Journal 2011 37 1 88 99 2-s2.0-79251547359 10.1183/09031936.00115110
16. Pai M., Zwerling A., Menzies D., Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Annals of Internal Medicine 2008 149 3 177 184 2-s2.0-48749127991
17. Yilmaz N., Aydin S. Z., Inanc N., Karakurt S., Direskeneli H., Yavuz S., Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients. Lupus 2012 21 5 491 495 2-s2.0-84859318007 10.1177/0961203311430700
18. Takeda N., Nojima T., Terao C., Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus. Lupus 2011 20 8 792 800 2-s2.0-80052726077 10.1177/ 0961203310397966
19. American Thoracic Society, Centers for Disease Control Prevention Infectious Disease Society of America, Targeted tuberculin testing and treatment of latent tuberculosis infection. The American Journal of Respiratory and Critical Care Medicine 2000 161 3 S221 S247 10.1164/ajrccm.161.supplement-3. ats600
20. Alcaide F., Santi M., Multidrug-resistant tuberculosis. Enfermedades Infecciosas y Microbiología Clínica 2008 26 supplement 13 54 60
21. Font C. V., Hernández-García C., Pato E., Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases. Revista Clínica Española 2003 203 4 178 182 10.1016/S0014-2565(03) 71232-6 (Pubitemid 36656552)
22. Rodriguez E., Villarrubia S., Diaz O., Situación de la tuberculosis en España. Casos de tuberculosis declarados a la Red Nacional de Vigilancia Epidemiológica 2010. Boletín Epidemiológico Semanal ISCIII 2012 20 26 41
23. Fedor M., Rubinstein A., Effects of long-term low-dose corticosteroid therapy on humoral immunity. Annals of Allergy, Asthma and Immunology 2006 97 1 113 116 2-s2.0-33746646343 (Pubitemid 44156348)
24. Kim K. H., Lee S. W., Chung W. T., Serial Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents. The Korean Journal of Laboratory Medicine 2011 31 14 271 278 10.3343/kjlm.2011.31.4.271
25. Pascual-Ramos V., Hernández-Cruz B., Villalobos I., Sifuentes-Osornio J., Alcocer-Varela J., Purified protein derivative reaction in systemic lupus erythematosus patients. Indirect study of cellular immunity. Lupus 2002 11 1 25 30 2-s2.0-0036176198 10.1191/0961203302lu142oa (Pubitemid 34178116)
26. Behar S. M., Shin D. S., Maier A., Coblyn J., Helfgott S., Weinblatt M. E., Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy. Journal of Rheumatology 2009 36 3 546 551 2-s2.0-65649093724 10.3899/jrheum.080854
27. Haynes B. F., Fauci A. S., The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. Journal of Clinical Investigation 1978 61 3 703 707 2-s2.0-0017950777
28. Ruiz-Irastorza G., Olivares N., Ruiz-Arruza I., Martinez-Berriotxoa A., Egurbide M., Aguirre C., Predictors of major infections in systemic lupus erythematosus. Arthritis Research & Therapy 2009 11 4, article R109 2-s2.0-73349136001 10.1186/ar2764